NL-OMON32080CompletedNot Applicable
Ciculating endothelial cells in Preeclampsia - CEC study
Erasmus MC, Universitair Medisch Centrum Rotterdam0 sites30 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Case group:
- •- diagnosis of severe preeclampsia based upon the ACOG criteria
- •- written informed consent
- •Control group:
- •- ASA class I pregnant patients visiting our out-patient clinic
- •- written informed consent
Exclusion Criteria
- •Control group:
- •- ASA class II or more
- •- previous pregnancies with placental syndromes as preeclampsia, growth retardation and/or gestational diabetes
- •- placental syndrome during the index pregnancy
Investigators
Similar Trials
Completed
Not Applicable
The change of endothelial function of preeclampsia patients during the treatmentspreeclampsia and pregnancy induced hypertensionJPRN-UMIN000014489Dept. of Obstetrics and Gynecology Osaka Medical College90
Completed
Not Applicable
Placental Expression of EG-VEGF and Its PROKR1 and PROKR2 Receptors in Preeclampsia Patients.PreeclampsiaNCT04846686Centre Hospitalier Universitaire de Saint Etienne35
Withdrawn
Not Applicable
Decidual vasculopathy in preeclampsia 3: Prediction and early detectio10026908HELLP syndromepreeclampsiaNL-OMON35148niversitair Medisch Centrum Sint Radboud70
Unknown
Not Applicable
Prospective Study in Pregnant Women With HypercoagulopathyPre-EclampsiaEclampsiaNCT00215969Hillerod Hospital, Denmark600
Completed
Not Applicable
Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes MellitusPreeclampsiaType 1 DiabetesNCT01821053Odense University Hospital85